April 12, 2021
Tailocins, which are extremely strong protein nanomachines made by bacteria, and their functions are an area of hot research due to their many possible applications. Scientists at the Berkeley Lab explored the genetic basis and physical mechanisms governing how tailocins attack specific strains, and looked at genetic similarities and differences between tailocin producers and their target strains.
April 06, 2021
Mike Holmes, PhD, is the Chief Scientific Officer at Ambys Medicines and is joining the QB3-Berkeley Professionals in Residence (PIR) program on April 16th and 23rd. He spoke with PhD student Diana Aguilar Gómez about his career from being a graduate student to industry and his pioneering work in genome editing techniques in gene therapy.
April 01, 2021
UC Berkeley researchers have invented a computer algorithm that uses deep learning to integrate gene and protein data about single cells.
April 01, 2021
CRISPR-Cas9 treatment of sickle cell disease has been approved for clinical trials by the U.S. Food and Drug Administration. Researchers will now test CRISPR-Cas9 on humans to directly correct the mutation in the beta-globin gene responsible for sickle cell disease.
March 25, 2021
Graduate student Riley Fricke sits down with Jeff Pelton, the manager of QB3-Berkeley’s 900 MHz NMR Facility, to discuss the facility and recent research that NMR spectroscopy has helped support.
March 15, 2021
Acclaimed biographer Walter Isaacson comes out with his new biography “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race,” which focuses on biotechnology and one of today’s scientific luminaries: UC Berkeley biochemist Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry.
March 11, 2021
Your generosity is especially impactful on Big Give! Please consider donating to the QB3-Berkeley to support our community and its programs.
March 10, 2021
Mary West, the director of the Cell and Tissue Analysis Facility and the High Throughput Screening Facility, explains how core facilities increase researchers’ access to equipment and highlights how these facilities play a crucial role in supporting labs’ work during campus COVID-19 restrictions.